ciclesonide nasal spray

DRUG3 trials

Sponsors

AstraZeneca, Sumitomo Pharma America, Inc.

Conditions

Hay FeverPerennial Allergic RhinitisRhinitis, Allergic, SeasonalSeasonal Allergic Rhinitis

Phase 3

Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)

CompletedNCT00305487

AstraZenecaHay Fever, Seasonal Allergic Rhinitis

Start: 2006-03-31End: 2006-10-31Target: 660Updated: 2016-11-30

A Study of Ciclesonide Nasal Spray in Patients 18 Years and Older With Seasonal Allergic Rhinitis (BY9010/M1-413)

CompletedNCT00384475

AstraZenecaHay Fever, Rhinitis, Allergic, Seasonal

Start: 2006-10-31End: 2007-01-31Target: 500Updated: 2016-11-30

Phase 4

A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR)

CompletedNCT01654536

Sumitomo Pharma America, Inc.Perennial Allergic Rhinitis

Start: 2012-09-30End: 2013-07-31Updated: 2014-07-24